Get started
Keyword

SHIFT trial

Description: The SHIFT trial was a clinical study evaluating ivabradine treatment for patients with chronic heart failure and elevated heart rates.
OpenAlex ID: keywords/shift-trial
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
2010 · Karl Swedberg, Michel Komajda, et al. · The Lancet · 2,566
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
2010 · Michael Böhm, Karl Swedberg, et al. · The Lancet · 1,099
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy
2011 · Jean-Claude Tardif, Eileen O'Meara, et al. · European Heart Journal · 300
Effects on Outcomes of Heart Rate Reduction by Ivabradine in Patients With Congestive Heart Failure: Is There an Influence of Beta-Blocker Dose?
2012 · Karl Swedberg, Michel Komajda, et al. · Journal of the American College of Cardiology · 262
PDF
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study
2012 · Michael Böhm, Jeffrey Borer, et al. · Clinical Research in Cardiology · 248
Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study
2011 · Inger Ekman, Olivier Chassany, et al. · European Heart Journal · 206
PDF
Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
2012 · J. S. Borer, M. Bohm, et al. · European Heart Journal · 142
PDF
Selective Heart Rate Reduction With Ivabradine Unloads the Left Ventricle in Heart Failure Patients
2013 · Jan-Christian Reil, Jean-Claude Tardif, et al. · Journal of the American College of Cardiology · 122
PDF
Heart rate reduction in coronary artery disease and heart failure
2016 · Roberto Ferrari, Kim Fox · Nature Reviews Cardiology · 106
Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: An efficacy and safety analysis of SHIFT study
2013 · L. Tavazzi, K. Swedberg, et al. · International Journal of Cardiology · 102
Rationale and Design of a Randomized, Double-Blind, Placebo-Controlled Outcome Trial of Ivabradine in Chronic Heart Failure: The Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial (SHIFT)
2009 · Karl Swedberg, Michel Komajda, et al. · European Journal of Heart Failure · 100
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
2011 · M.D. Cheitlin · Yearbook of Cardiology · 98
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials
2013 · Kim Fox, Michel Komajda, et al. · European Heart Journal · 95
PDF
Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure
2012 · D. Castagno, M. C. Petrie, et al. · European Heart Journal · 83
PDF
Efficacy and Safety of Ivabradine in Chronic Heart Failure Across the Age Spectrum: Insights from the SHIFT Study
2013 · Luigi Tavazzi, Karl Swedberg, et al. · European Journal of Heart Failure · 78
PDF
Efficacy and Safety of Ivabradine in Patients with Chronic Systolic Heart Failure and Diabetes: An Analysis from the SHIFT Trial
2015 · Michel Komajda, Luigi Tavazzi, et al. · European Journal of Heart Failure · 76
PDF
Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure ― J-SHIFT Study ―
2019 · Hiroyuki Tsutsui, Shin-ichi Momomura, et al. · Circulation Journal · 73
PDF
Efficacy and Safety of Ivabradine in Patients with Chronic Systolic Heart Failure According to Blood Pressure Level in SHIFT
2014 · Michel Komajda, Michael Böhm, et al. · European Journal of Heart Failure · 71
PDF
The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
2014 · A Griffiths, N Paracha, et al. · Heart · 70
PDF
Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)
2015 · Michael Böhm, Michele Robertson, et al. · The American Journal of Cardiology · 64
Twenty-Four-Hour Heart Rate Lowering with Ivabradine in Chronic Heart Failure: Insights from the SHIFT Holter Substudy
2015 · Michael Böhm, Jeffrey S. Borer, et al. · European Journal of Heart Failure · 61
PDF
Heart Rate and Heart Failure - Not a Simple Relationship -
2010 · Gerd Heusch · Circulation Journal · 60
PDF
The Effect of Heart Rate Reduction with Ivabradine on Renal Function in Patients with Chronic Heart Failure: An Analysis from SHIFT
2014 · Adriaan A. Voors, Dirk J. van Veldhuisen, et al. · European Journal of Heart Failure · 57
PDF
Heart Rate and its Reduction in Chronic Heart Failure and Beyond
2017 · Aleksandra Nikolovska Vukadinović, Davor Vukadinović, et al. · European Journal of Heart Failure · 52
PDF
Duration of Chronic Heart Failure Affects Outcomes with Preserved Effects of Heart Rate Reduction with Ivabradine: Findings from SHIFT
2017 · Michael Böhm, Michel Komajda, et al. · European Journal of Heart Failure · 50
PDF
Works count: 269
Citation count: 7,607
Year
Topic
Type